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Copyright © 2008 JCBN Summary Heme oxygenase (HO) catalyzes the rate-limiting step in heme degradation to
produce carbon monoxide (CO), iron, and biliverdin. Biliverdin is subsequently converted to
bilirubin by its reductase, and iron is recycled for heme synthesis. The inducible HO isoform,
HO-1, is involved in the protection of multiple tissues and organs. The mechanism of protec-
tive actions of HO-1 has not been completely elucidated, but recent evidence suggests that one
or more of heme metabolites can mediate the protective effects of HO-1. Particularly, CO
mimics the antioxidant, anti-inflammatory, anti-apoptotic and antiproliferative actions of HO-
1. Many of these effects of CO depend on the production of cyclic guanosine monophosphate
(cGMP), and the modulation of mitogen-activated protein kinase (MAPK) pathways. The
transcription factors, including nuclear factor E2-related factor-2 (Nrf2), and their upstream
kinases, including MAPK pathway, play an important regulatory role in HO-1 expression by
dietary antioxidants and drugs. This review attempts to concisely summarize the molecular
and biochemical characteristics of HO-1, with a discussion on the mechanisms of signal trans-
duction and gene regulation that mediate the induction of HO-1 by dietary antioxidants and
drugs. In addition, the cytoprotective roles of HO-1 shall be discussed from the perspective of
each of the metabolic by-products.
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Introduction
Heme, a complex of ferrous iron and protoporphyrin IX,
has a variety of biological functions, including oxygen
binding, electron transport, and chemical catalysis [1].
Various types of proteins contain this molecule as theirH.-O. Pae et al.
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prosthetic group. When these proteins turn over, the heme is
not salvaged but degraded by the enzyme heme oxygenase
(HO) [2]. HO catalyzes the first and rate-limiting step in the
oxidative degradation of free heme to produce equimolar
quantities of carbon monoxide (CO), ferrous iron, and
biliverdin (BV) [3]. BV is subsequently converted to
bilirubin (BR) by a BV reductase, and iron is recycled for
heme synthesis. Two genetically distinct isozymes of HO
have been characterized: an inducible form, heme oxygenase-
1 (HO-1), and a constitutively expressed form, heme
oxygenase-2 (HO-2). Although both HO-1 and HO-2
catalyze the identical biochemical reaction, they differ in
genetic origin, in primary structure, in molecular weight,
and in their substrate and kinetic parameters [4]. Moreover,
HO-1, once expressed, can metabolize high amounts of free
heme to produce high concentrations of its enzymatic by-
products that may affect various biological events. HO-1 can
be expressed primarily by its substrate, free heme, and also
by a wide variety of stimuli, inducing hypoxia, hyperoxia,
pro-inflammatory cytokines, nitric oxide (NO), heavy
metals, ultraviolet radiation, heat shock, shear stress, and
hydrogen peroxide [4, 5]. This adaptive response of HO-1 to
these cytotoxic stimuli implies that HO-1, besides its role in
heme degradation, may function as a critical cytoprotective
molecule.
This review attempts to concisely summarize the mole-
cular and biochemical characteristics of HO-1, with a dis-
cussion on the important mechanisms of signal transduction
and gene regulation that mediate the induction of HO-1
particularly by dietary antioxidants and drugs. In addition,
the integrative survival response evoked by HO-1 shall be
discussed from the perspective of each of the metabolic by-
products.
HO-1 Deficiency
Essential lessons from the analysis of HO-1-deficient
human case and mice indicate that HO-1 is involved in the
protection of multiple tissues and organs and that cyto-
protection afforded by HO-1 is associated with its anti-
oxidant, anti-inflammatory, anti-apoptotic and antiprolifera-
tive effects.
Mice
Poss and Tonegawa [6, 7] have first reported that HO-1-
deficient mice are extremely sensitive to oxidative injury,
thus establishing that HO-1 is an important cytoprotective
system. The HO-1-deficient mice exhibited a decreased
birth rate, growth retardation, anemia, tissue iron deposition,
hepatosplenomegaly, lymphadenopathy, leukocytosis, and
glomerulonephritis [8]. The HO-1-deficient mice developed
a chronic inflammatory state that progresses with age [9].
Human
Yachie and colleagues [10–12] have reported the first
human case of HO-1 deficiency in a 6-yr-old boy. The child
suffered from similar symptoms as the HO-1-deficient mice,
including growth failure, anemia, increased iron binding
capacity, tissue iron deposition, lymphadenopathy, leuko-
cytosis, and increased sensitivity to oxidant injury [8].
The HO-1-deficient human case died of an inflammatory
syndrome [8, 11].
HO-1 Expression
A number of intracellular signaling molecules and their
downstream transcription factors have been identified to
involve HO-1 expression [13]. Among them, the mitogen-
activated protein kinase (MAPK), as one of upstream
pathways, and the nuclear factor E2-related factor 2 (Nrf2),
as one of downstream transcription factors, are well
described to be more important in HO-1 expression by non-
toxic phytochemicals and drugs [13, 14], and thus briefly
discussed below (Fig. 1).
MAPK pathway
The MAPK super-family comprises three primary
signaling cascades: the extracellular signal regulated kinase
(ERK), the c-Jun NH2-terminal kinase or stress-activated
kinase (JNK/SAPK), and the p38 MAPK. Recent studies
have focused on the roles of MAPK pathways in HO-1
expression in diverse cell types in response to various
stimuli [14]. For examples, curcumin stimulates HO-1
expression through p38 MAPK pathway [15–18]. α-Lipoic
acid induces HO-1 expression through ERK pathway [19].
Paclitaxel induces the expression of HO-1 via JNK pathway
[20]. Interestingly, the inhibition of ERK, JNK, or p38
MAPK activation individually is insufficient to completely
abolish HO-1 expression by oxidized low density lipo-
protein; however, inhibition of these MAPK pathways in
combination results in a significantly greater attenuation of
HO-1 expression [21], suggesting that these MAPK path-
ways act in concert to regulate HO-1 expression.
Nrf2 activation
Nrf2 is a member of the basic leucine zipper family of
transcription factors. Under normal physiological condi-
tions, Nrf2 resides in the cytoplasm bound to its inhibitor
protein, Keap-1, an actin-binding protein. On stimulation,
Nrf2 is released from Keap-1 and rapidly translocates into
the nucleus, where it binds to a DNA sequence in target
genes [22]. The important role of Nrf2 in the stress-
dependent expression of HO-1 has been highlighted by the
finding that HO-1 is less inducible in Nrf2-deficient mice
[23]. Moreover, transduction of vascular smooth muscle
cells with Nrf2-expressing adenovirus increased cyto-Survival Response by HO-1 and Its Products
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protective HO-1 expression [24].
Integrative Survival Response Evoked by HO-1 and
Heme Metabolites
Although the protective effects of HO-1 have been con-
firmed in a number of experimental models, the mechanism
of its action has not been completely elucidated. Degrada-
tion of the pro-oxidant heme by HO-1 appears to first aid in
tissue protection; however, recent evidence suggests that one
or more of the by-products of its heme catabolism (CO, free
iron or BV/BR) mediates the cytoprotective effects of HO-1
[4] (Fig. 2).
Heme degradation
Heme is inherently dangerous when released from intra-
cellular heme-containing proteins [1]. It offers toxic effects
to tissues and organs through oxidative stress by generating
reactive oxygen species (ROS) via Fenton reaction [25],
which may promote membrane lipid peroxidation and
inflammation. Thus, heme catabolism by HO-1 is the first
important antioxidant mechanism for survival from the
redox environment induced by free heme. It should be noted
that the insufficient catabolism of free heme by HO-1 may
induce disturbances of the iron-reuse system, causing iron-
deficiency anemia as already evidenced in HO-1-deficient
human and mice [8].
CO
Although the gaseous CO is classically thought of as a
toxic molecule and cellular asphyxiate, recent studies have
revealed that CO has profound effects on the intracellular
signaling processes, culminating in anti-inflammatory, anti-
proliferative, and anti-apoptotic effects (excellently reviewed
in Ref. 4). The pleiotropic effects of CO may involve two
general mechanisms; CO can activate soluble guanylyl
cyclase (sGC), with the resultant production of cyclic
guanine monophosphate (cGMP), and CO can modulate
MAPK pathway. CO, like NO, binds to the heme moiety of
sGC, leading to the stimulation of sGC and subsequent
elevation of cGMP levels that causes protective vascular
relaxation [26]. Other cGMP-mediated effects of CO include
the inhibition of platelet aggregation [27] and vascular
smooth muscle proliferation [26], and the protection of
pancreatic β cells from apoptosis [28]. Most interestingly,
CO induces a general down-regulation of pro-inflammatory
cytokine production through MAPK-dependent pathway,
leading to anti-inflammatory tissue protection [29,  30].
Also, both anti-apoptotic and antiproliferative actions of CO
involve the MAPK pathway [31, 32].
Iron and ferritin
Although ferrous iron, an extremely pro-oxidative mole-
cule, is released during the breakdown of free heme by HO-
1, the iron is rapidly removed by ferritin, a ubiquitously
existing intracellular protein that is able to effectively
sequester intracellular iron and, hence, limit its pro-oxidant
capacity. Thus, it is not surprising that ferritin expression is
enhanced in conjunction with HO-1 expression [33]. Ferritin
synthesized as a consequence of HO-1 activity has been
implicated as a cytoprotective molecule in a number of
experimental models [34].
BV/BR
In cellular system, the soluble greenish pigment BV is
rapidly converted by BV reductase into the hydrophobic
yellowish pigment BR. BR is now recognized as being a
potent antioxidant manufactured by the body, because BR
can directly scavenge ROS and reduce ROS production [35].
By virtue of its ROS-scavenging capacity, BR confers
cardiovascular, hepatic, and neural protection [35]. More-
Fig. 1. Signaling pathways leading to HO-1 expression by
phytochemicals and drugs through MAPK-dependent
Nrf2 activation. Besides MAPK, protein kinase C
(PKC), phosphatidylinositol 3-kinase (PI3K), and RNA-
dependant protein kinase-like endoplasmic reticulum
kinase (PERK), depending on cell types and agent
properties, have been also implicated in Nrf2 activation.
Other transcription factors that also regulate HO-1
expression include heat-shock factor (HSF), nuclear
factor-erythroid 2 (NF-E2), activator protein-1 (AP-1),
and nuclear factor-κB (NF-κB). Upon external stimuli,
the active forms of these transcription factors translocate
to the nucleus where they bind to the specific DNA
sequence leading to the transcription of HO-1 gene.
Some phytochemicals directly activate Nrf2 nuclear
translocation or indirectly through ROS generation.H.-O. Pae et al.
J. Clin. Biochem. Nutr.
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over, it is becoming clear that low plasma concentrations of
BR are associated with a low incidence of cardiovascular
disorders in humans (e.g., atherosclerosis and ischemic heart
disease) [36].
HO-1 Inducer
As HO-1 expression is widely recognized as an effective
cellular strategy to counteract a variety of stressful events
[4], the induction of HO-1 by pharmacological modulators
may represent a novel target for therapeutic intervention.
Particularly, the identification of non-cytotoxic HO-1
inducers may maximize the intrinsic protective potential of
cells.
Phytochemicals
Several antioxidants from plant origins and drugs have
been reported to induce HO-1 expression in various types of
cells [37]. Among them, curcumin (Fig. 3A), a polyphenolic
compound isolated from the rhizome of Curcuma longa
Linn (Zingiberaceae), is well characterized as a non-
cytotoxic HO-1 inducer in endothelial cells [16], astrocytes
[38], macrophages [39], and vascular smooth muscle cells
[40]. In the liver HepG2 cells, curcumin also induced HO-1
expression in a time- and dose-dependent manner (Fig. 3B).
Curcumin activated Nrf2 nuclear translocation (Fig. 3C),
which is presumably an upstream step of HO-1 expression.
The experiments designed to determine a possible role of
MAPK pathways in HO-1 expression by curcumin showed
that curcumin activates ERK and p38 MAPK pathways
(Fig. 3D), but not JNK pathway. Additionally, the use of
specific inhibitors for the MAPK pathways confirmed the
involvement of p38 MAPK pathway, but not of ERK or JNK
pathways, in HO-1 expression (Fig. 3E). Interestingly, pre-
incubation for 12 h with curcumin resulted in an enhanced
cellular resistance to the potent oxidant t-butylhydro-
peroxide; this cytoprotective effect was considerably
attenuated by zinc protoporphyrin IX, an inhibitor of HO
activity (Fig. 3F).
CO
Surprisingly, CO can induce HO-1 expression, raising a
possibility that CO may exert full effects not only through
the first pathway associated with its original ability but also
through the second pathway associated with HO-1 expres-
sion that, in addition to CO-mediated effects, may provide
other effects. In this regard, CO may serve as an effective
HO-1 inducer. Sawle and coworkers [41] originally demon-
strated that a CO-releasing molecule (CORM) increased
HO-1 expression and HO activity. However, they did not
explore the cellular mechanism for this effect of CO on HO-
1 expression, as well as its physiological significance. Later,
Lee and coworkers [42] confirmed that both CO gas and
CORM induced HO-1 expression via Nrf2-dependent
pathway in HepG2 cells and primary rat hepatocytes. This is
further confirmed by Kim and coworkers [43]. They demon-
strated that exogenous CO activated Nrf2 through the phos-
phorylation of protein kinase R-like endoplasmic reticulum
kinase (PERK), resulting in HO-1 expression. CO-induced
activation of PERK was followed by the phosphorylation of
eukaryotic translation initiation factor 2 and the expression
of activating transcription factor 4. However, CO failed to
Fig. 2. Potential signaling pathways activated by HO-1 and heme metabolites leading to tissue protection. HO-1 reduces the pro-
oxidant heme through enzymatic reaction. Iron released from this reaction triggers pathways involving the activation of the iron
regulatory protein, leading to its sequestration and recycle. BR and BV potentially contribute to cellular antioxidant balance
prior to their excretion. CO activates sGC, resulting in production of cGMP. CO also modulates MAPK pathways, thereby
leading to anti-inflammatory, anti-apoptotic, and antiproliferative effects. The solid and dotted arrow lines shows either an
increase or activation and either a decrease or inactivation, respectively.Survival Response by HO-1 and Its Products
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induce X-box binding protein-1 (Xbp-1) expression and
activating transcription factor 6 (ATF6) cleavage. Instead,
CO prevented Xbp-1 expression and ATF6 cleavage induced
by endoplasmic reticulum (ER) stress inducers such as
tunicamycin. They also demonstrated that CO rendered
endothelial cells resistant to ER stress, which is potentially
therapeutic in vascular diseases associated with ER stress.
CO prevented endothelial apoptosis triggered by ER stress
inducers through the suppression of C/EBP homologous
protein (CHOP) expression, which was associated with its
activation of p38 MAPK. The endogenous CO produced
from HO-1 was also cytoprotective against ER stress
through CHOP suppression.
Conclusion
Growing evidence supports HO-1 as an ‘omnipotent’
protein that, when expressed in a variety of disease states,
exerts numerous activities that offer tissue protection. The
precise underlying mechanisms for HO-1-based protection
are not yet completely understood, but appear to involve
the effects of by-products of HO-1 activity on intracellular
signaling pathways. Overall, the ultimate goal of most
research in HO-1 is to find a therapeutic use, and there could
be several approaches to this issue. Transfer of HO-1 gene
and administration of the reaction products of HO-1 have
been attempted in animals with promising results, but not in
human studies, probably due to potentially injurious effects.
However, it is worth mentioning that several dietary anti-
oxidants, of which safety is well characterized in humans,
can induce HO-1 expression in a variety of cell types, and
this may be a mechanism for their beneficial effects in
several diseases. Further studies are required to investigate
the effects of other dietary antioxidants and examine the
signaling pathways involved in HO-1 expression.
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presence of inhibitors for MAPK pathways, and Western blotting analysis for HO-1 expression and phosphorylation of ERK,
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curcumin, and exposed for 6 h to 30 µM of ter-butylhydroperoxide in the absence or presence of 20 µM of zinc protoporphyrin
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